iVolution pro Stent
Peripheral artery disease
Post-MarketActive
Key Facts
About iVascularU
iVascular is a privately-held, commercial-stage medical device company focused on the cardiovascular and neurovascular markets. Leveraging deep expertise in biopolymers, coatings, and drug delivery, the company has built a vertically integrated platform to develop and manufacture a portfolio of interventional devices, including the Angiolite drug-eluting stent and Luminor drug-coated balloon. With products approved in over 70 countries and a growing clinical evidence base, iVascular aims to be a European reference in vascular therapy through innovation and close collaboration with physicians.
View full company profileTherapeutic Areas
Other Peripheral artery disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Peripheral Artery Disease Program | Elixir Medical | Pre-clinical |
| Aperta NSE™ PTA | Nipro Medical | Commercial |
| JTV-263 | Akros Pharma | Phase1 |
| Luminor DCB | iVascularU | Post-Market |
| FGF-1 | Zhittya Genesis Medicine | Phase 2 |
| ChampioNIR | Medinol | Investigational |
| Peripheral Stent | Advanced Biomed | Approved |
| Ranger DCB | Boston Scientific | Pivotal Trial |